Addressing Preclinical Alzheimer’s: Researchers Caution Against Overtreatment

You are here

Mon, August 05, 2019

Kenneth Langa and James Burke wrote a Viewpoint in a recent edition of JAMA Internal Medicine about the potential for overdiagnosis and high costs if treatment for preclinical Alzheimer’s disease becomes widely used. Langa was also a co-author on a recent JAMA paper that addressed preventing dementia. Langa and his colleagues found that people with a healthier lifestyle had a lower risk for dementia in later life, even if they had genes that put them at high genetic risk.

Research Topics: